Product NDC 49702-0246

3 active presentations under this Product NDC family.

Review package-specific NDC rows, compare configurations, and request pricing through the RFQ workflow.

Need a Product Not Listed?

Submit a custom quote request for unlisted NDCs, item codes, or alternate product presentations.

Drug Catalog Search | Request a Custom Quote

Family context

Product NDC 49702-0246 groups closely related presentations under the same catalog family, giving healthcare teams a clearer path for comparing packaging and alternate exact NDC rows before an RFQ is submitted.

  • Family size: 3 active presentations.
  • Generic family: dolutegravir sodium and lamivudine.
  • Primary dosage form: Tablet.
  • Common strength: 50 mg / 1; 300 mg / 1.

What changes inside this family

Use the family page to compare formats, then click into the exact NDC page that matches the package your team needs.

  • Manufacturers shown: ViiV Healthcare Company.
  • Dosage forms shown: Tablet.
  • Package quantities: 1 Blister Pack and 30 Tablet, Film Coated.

Manufacturer pathways

Official family references

Use official family-level references to verify labeling context while comparing the child NDC presentations shown on this page.

Showing page 1 of 1
dolutegravir sodium and lamivudine 50 mg / 1; 300 mg / 1 Tablet 1 Blister Pack (Dovato)49702-0246-3350 mg / 1; 300 mg / 1Tablet1 Blister Pack
dolutegravir sodium and lamivudine 50 mg / 1; 300 mg / 1 Tablet 1 Blister Pack (Dovato)49702-0246-6250 mg / 1; 300 mg / 1Tablet1 Blister Pack
dolutegravir sodium and lamivudine 50 mg / 1; 300 mg / 1 Tablet 30 Tablet, Film Coated (Dovato)49702-0246-1350 mg / 1; 300 mg / 1Tablet30 Tablet, Film Coated

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.